C12N 2320/33
Alteration of splicing
C12N2320/33 (Alteration of splicing) appears on 477 US grants and 1,159 published applications in this corpus.
Search patents in C12N- Granted patents
- 477
- Published applications
- 1,159
- Assignees
- 355
- Inventors
- 1,452
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 1 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 5 |
| 2007 | 0 | 5 |
| 2008 | 1 | 2 |
| 2009 | 2 | 9 |
| 2010 | 3 | 8 |
| 2011 | 5 | 16 |
| 2012 | 4 | 26 |
| 2013 | 14 | 23 |
| 2014 | 12 | 51 |
| 2015 | 19 | 42 |
| 2016 | 33 | 43 |
| 2017 | 33 | 64 |
| 2018 | 29 | 61 |
| 2019 | 46 | 76 |
| 2020 | 46 | 71 |
| 2021 | 48 | 93 |
| 2022 | 38 | 118 |
| 2023 | 31 | 92 |
| 2024 | 47 | 114 |
| 2025 | 32 | 138 |
| 2026 | 32 | 96 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antisense oligonucleotides for the treatment of stargardt disease29 Sep 2026US 12,747,440 B2ProQR Therapeutics II B.V.
- Trans-splicing ribozyme specific to ApoE4 RNA and use thereof15 Sep 2026US 12,735,701 B2Rznomics Inc.
- Antisense molecules and methods for treating pathologies18 Aug 2026US 12,709,749 B2The University of Western Australia
- Precision medicine portal for human diseases4 Aug 2026US 12,700,511 B2Genome International Corporation
- Methods and compositions for trans-splicing utilizing trifunctional elements21 Jul 2026US 12,686,869 B1Amber Bio Inc.
- Reducing intron retention8 Oct 2026US 2026/0308583 A1University of Southampton
- Compositions and methods for regulating expression of atxn28 Oct 2026US 2026/0308591 A1Riboway Therapeutics, Inc.
- Antisense oligomer formulations8 Oct 2026US 2026/0308595 A1Stoke Therapeutics, Inc.
- Methods of minimising effects of smoke exposure8 Oct 2026US 2026/0308597 A1Rage Biotech Pty Ltd
- Compositions and methods for treating stxbp1 disorders24 Sep 2026US 2026/0286357 A1Biomarin Pharmaceutical Inc.
Most cited
By later US patents
- Induction of exon skipping in eukaryotic cells154US 7,973,015 B2Academisch Ziekenhuis Leiden · 2011
- Means and method for inducing exon-skipping148US 8,361,979 B2Academisch Ziekenhuis Leiden · 2013
- Antisense oligonucleotides for inducing exon skipping and methods of use thereof143US 7,960,541 B2The University of Western Australia · 2011
- Antisense oligonucleotides for inducing exon skipping and methods of use thereof137US 8,232,384 B2The University of Western Australia · 2012
- Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure135US 7,534,879 B2Academisch Ziekenhuis Leiden · 2009